Anna B. Berry

948 total citations
37 papers, 461 citations indexed

About

Anna B. Berry is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Anna B. Berry has authored 37 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cancer Research, 10 papers in Pulmonary and Respiratory Medicine and 10 papers in Genetics. Recurrent topics in Anna B. Berry's work include Cancer Genomics and Diagnostics (14 papers), BRCA gene mutations in cancer (7 papers) and Bladder and Urothelial Cancer Treatments (6 papers). Anna B. Berry is often cited by papers focused on Cancer Genomics and Diagnostics (14 papers), BRCA gene mutations in cancer (7 papers) and Bladder and Urothelial Cancer Treatments (6 papers). Anna B. Berry collaborates with scholars based in United States, United Kingdom and India. Anna B. Berry's co-authors include Badrinath R. Konety, Peter R. Carroll, Kirsten L. Greene, Jared M. Whitson, John D. Pfeifer, Philip A. Fine, Burton S. Rosner, Sophia Yohe, Eugene R. Passamani and John F. Tooker and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

Anna B. Berry

34 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna B. Berry United States 11 132 112 111 104 102 37 461
Jane S. Gibson United States 7 96 0.7× 51 0.5× 202 1.8× 164 1.6× 194 1.9× 7 495
JoEllen Weaver United States 9 237 1.8× 48 0.4× 208 1.9× 249 2.4× 46 0.5× 13 511
Krisztián Látó Germany 10 98 0.7× 121 1.1× 13 0.1× 46 0.4× 102 1.0× 26 333
Michael Jewett Canada 9 217 1.6× 94 0.8× 45 0.4× 118 1.1× 29 0.3× 22 397
Raquel Garza‐Guajardo Mexico 11 86 0.7× 101 0.9× 42 0.4× 107 1.0× 58 0.6× 42 384
C Fox Australia 6 89 0.7× 268 2.4× 41 0.4× 50 0.5× 298 2.9× 7 527
S. Srinivas United States 8 40 0.3× 125 1.1× 81 0.7× 94 0.9× 33 0.3× 33 290
Preeti Singh India 10 51 0.4× 74 0.7× 39 0.4× 74 0.7× 32 0.3× 38 314
Aine Clements United States 13 78 0.6× 136 1.2× 52 0.5× 90 0.9× 66 0.6× 27 422
Maria Bjurberg Sweden 15 104 0.8× 137 1.2× 23 0.2× 92 0.9× 41 0.4× 37 542

Countries citing papers authored by Anna B. Berry

Since Specialization
Citations

This map shows the geographic impact of Anna B. Berry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna B. Berry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna B. Berry more than expected).

Fields of papers citing papers by Anna B. Berry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna B. Berry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna B. Berry. The network helps show where Anna B. Berry may publish in the future.

Co-authorship network of co-authors of Anna B. Berry

This figure shows the co-authorship network connecting the top 25 collaborators of Anna B. Berry. A scholar is included among the top collaborators of Anna B. Berry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna B. Berry. Anna B. Berry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Bapat, Bela, Monika A. Izano, Molly Scannell Bryan, et al.. (2024). Real-World Impact of Comprehensive Genomic Profiling on Biomarker Detection, Receipt of Therapy, and Clinical Outcomes in Advanced Non–Small Cell Lung Cancer. JCO Precision Oncology. 8(8). e2400075–e2400075. 7 indexed citations
4.
Bryan, Molly Scannell, Xiaohan Hu, Monika A. Izano, et al.. (2024). Social determinants of health and variability in treatment for patients with early-stage non-small cell lung cancer. JNCI Cancer Spectrum. 9(2).
5.
Kaplan, Henry G., et al.. (2024). Multi-omic profiling of simultaneous ductal carcinoma in situ and invasive breast cancer. Breast Cancer Research and Treatment. 205(3). 451–464. 2 indexed citations
6.
Simon, George R., Anna B. Berry, Bela Bapat, et al.. (2023). 1422P Comprehensive genomic profiling (CGP) changes management and improves survival in patients with advanced non-small cell lung cancer (aNSCLC). Annals of Oncology. 34. S812–S812. 1 indexed citations
7.
Berry, Anna B., et al.. (2023). Inferring Negative Molecular Biomarker Data at Scale. JCO Clinical Cancer Informatics. 7(7). e2200158–e2200158. 1 indexed citations
8.
Rosenbaum, Jason N., Anna B. Berry, Alanna J. Church, et al.. (2021). A Curriculum for Genomic Education of Molecular Genetic Pathology Fellows. Journal of Molecular Diagnostics. 23(10). 1218–1240. 2 indexed citations
9.
Cushman‐Vokoun, Allison M., Josh Lauring, John D. Pfeifer, et al.. (2021). Laboratory and Clinical Implications of Incidental and Secondary Germline Findings During Tumor Testing. Archives of Pathology & Laboratory Medicine. 146(1). 70–77. 16 indexed citations
10.
Walk, Eric, Sophia Yohe, Andrew E. Schade, et al.. (2019). The Cancer Immunotherapy Biomarker Testing Landscape. Archives of Pathology & Laboratory Medicine. 144(6). 706–724. 61 indexed citations
11.
Brown, Thomas D., Philip J. Gold, Charles W. Drescher, et al.. (2017). Abstract 997: Impact of a personalized medicine research program (PMRP), using targeted tumor profiling and a cloud based clinical trials matching platform, on clinical decision-making. Cancer Research. 77(13_Supplement). 997–997. 1 indexed citations
12.
Aisner, Dara L., Anna B. Berry, D. Brian Dawson, et al.. (2016). A Suggested Molecular Pathology Curriculum for Residents. Journal of Molecular Diagnostics. 18(2). 153–162. 9 indexed citations
13.
14.
Berry, Anna B., et al.. (2016). Nodular Fasciitis: Definitive Diagnosis by Fine Needle Aspiration. Acta Cytologica. 60(1). 19–24. 10 indexed citations
15.
16.
Odisho, Anobel Y., Anna B. Berry, Ardalan E. Ahmad, et al.. (2012). Reflex ImmunoCyt Testing for the Diagnosis of Bladder Cancer in Patients with Atypical Urine Cytology. European Urology. 63(5). 936–940. 28 indexed citations
17.
Whitson, Jared M., Anna B. Berry, Peter R. Carroll, & Badrinath R. Konety. (2009). A multicolour fluorescence in situ hybridization test predicts recurrence in patients with high‐risk superficial bladder tumours undergoing intravesical therapy. British Journal of Urology. 104(3). 336–339. 40 indexed citations
18.
Greenwald, Bruce D., et al.. (2008). Evaluation of performance of EUS‐FNA in preoperative lymph node staging of cancers of esophagus, lung, and pancreas. Diagnostic Cytopathology. 36(5). 290–296. 13 indexed citations
19.
Greene, Kirsten L., Anna B. Berry, & Badrinath R. Konety. (2006). Diagnostic Utility of the ImmunoCyt/uCyt+ Test in Bladder Cancer.. PubMed. 8(4). 190–7. 40 indexed citations
20.
Fine, Philip A., Anna B. Berry, & Burton S. Rosner. (2006). The effect of pattern recognition and tonal predictability on sight-singing ability. Psychology of Music. 34(4). 431–447. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jane S. Gibson Breakdown of academic impact, for papers by JoEllen Weaver Breakdown of academic impact, for papers by Krisztián Látó Breakdown of academic impact, for papers by Michael Jewett Breakdown of academic impact, for papers by Raquel Garza‐Guajardo Breakdown of academic impact, for papers by C Fox Breakdown of academic impact, for papers by S. Srinivas Breakdown of academic impact, for papers by Preeti Singh Breakdown of academic impact, for papers by Aine Clements Breakdown of academic impact, for papers by Maria Bjurberg
Rankless by CCL
2026